It appears you don't have support to open PDFs in this web browser. To view this file, Open with your PDF reader
Abstract
Background
The occurrence of psychotic features within mood episodes in patients with bipolar I disorder (BD I) has been associated in some studies with a more severe clinical and socio-professional profile. In contrast, other studies establishing the associations of psychotic features in BD I, and in particular of mood-congruent (MC) and mood-incongruent (MI) features, with clinical characteristics have yielded contradictory results. However, many pre-existing studies have been affected by serious methodological limitations. Using a sample of thoroughly assessed patients with BD I our aims were to: (1) establish the proportion of those with MI and MC features, and (2) compare BD I patients with and without psychotic features as well as those with MI to those with MC features on a wide array of socio-demographic and clinical characteristics including course, psychiatric comorbidity and treatment.
Methods
A sample of 162 treated patients with BD I (60.5% female, mean age = 41.4 (s.d: 10.2) years) was recruited within a large family study of mood disorders. Clinical, course and treatment characteristics relied on information elicited through direct diagnostic interviews, family history reports and medical records.
Results
(1) A total of 96 patients (59.3%) had experienced psychotic features over their lifetime. Among them, 44.8% revealed MI features at least once in their lives. (2) Patients with psychotic features were much less likely to be professionally active, revealed alcohol abuse more frequently and used health care, particularly inpatient treatment, more frequently than those without psychotic features. Within patients with psychotic symptoms, those with MI features showed more clinical severity in terms of a higher likelihood of reporting hallucinations, suicidal attempts and comorbid cannabis dependence.
Conclusion
Our data provide additional support for both the distinction between BD-I with and without psychotic features as well as the distinction between MI and MC psychotic features. The more severe course of patients with psychotic features, and particularly those with MI psychotic features, highlights the need for thorough psychopathological evaluations to assess the presence of these symptoms to install appropriate treatment.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Details
1 Lausanne University Hospital and University of Lausanne, Department of Psychiatry, Canton of Vaud, Switzerland (GRID:grid.9851.5) (ISNI:0000 0001 2165 4204); Lausanne University Hospital and University of Lausanne, Department of Psychiatry, Canton of Vaud, Switzerland (GRID:grid.9851.5) (ISNI:0000 0001 2165 4204)
2 Lausanne University Hospital and University of Lausanne, Department of Psychiatry, Psychiatric Epidemiology and Psychopathology Research Center, Prilly, Switzerland (GRID:grid.9851.5) (ISNI:0000 0001 2165 4204)
3 University Hospital of Lausanne and University of Lausanne, Child and Adolescent Psychiatry Clinics, Lausanne, Switzerland (GRID:grid.8515.9) (ISNI:0000 0001 0423 4662)
4 Intramural Research Program, National Institute of Mental Health, Genetic Epidemiology Research Branch, Bethesda, USA (GRID:grid.416868.5) (ISNI:0000 0004 0464 0574)
5 Lausanne University Hospital and University of Lausanne, Department of Psychiatry, Canton of Vaud, Switzerland (GRID:grid.9851.5) (ISNI:0000 0001 2165 4204)
6 Lausanne University Hospital and University of Lausanne, Department of Psychiatry, Center for Psychiatric Neuroscience, Prilly, Switzerland (GRID:grid.9851.5) (ISNI:0000 0001 2165 4204); Laval University, International Research Unit in Neurodevelopment and Child Psychiatry, Quebec, Canada (GRID:grid.23856.3a) (ISNI:0000 0004 1936 8390)